HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clearasil Launch Aims For Broader Control Of U.S. Skin Care Category

This article was originally published in The Rose Sheet

Executive Summary

Boots Healthcare International is launching Clearasil Total Control, a non-acne treatment skin care range, to fill a void in the mass market for products that offer basic skin care benefits to young women, the company said during a press event in New York City Dec. 10

You may also be interested in...



Clearasil For Men Uses Anti-Acne Positioning To Enter Men’s Market

Clearasil for Men, the brand's first acne treatment line designed specifically for men, is expected to generate roughly $12 mil. at retail in its first year on shelves, according to the Boots Healthcare division

Clearasil For Men Uses Anti-Acne Positioning To Enter Men’s Market

Clearasil for Men, the brand's first acne treatment line designed specifically for men, is expected to generate roughly $12 mil. at retail in its first year on shelves, according to the Boots Healthcare division

Clearasil Ultra Treatment Bows With Neostrata AHA Technology

Boots will launchClearasil Ultra Treatment Cream in March formulated with patented alpha hydroxy acid technology from Neostrata

Related Content

UsernamePublicRestriction

Register

RS010814

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel